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Background: Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is the most common orofacial birth
defect with a wide range prevalence among different populations. Previous association studies with populations
from Europe and Asia have identified putative susceptibility markers for NSCL/P in fibroblast growth factor 12
(FGF12), vinculin (VCL), connexin 43 (CX43) and in a region close to the ventral anterior homeobox 1 (VAX1) gene.
However, there have thus far been no studies of these markers in NSCL/P Brazilian patients, and as the genetic
ancestry of the Brazilian population is highly varied, the predisposition to those disease markers can be different.
Methods: Herein we conducted a structured association study conditioned on the individual ancestry proportions
to determine the role of 16 polymorphic markers within those genes in 300 patients with NSCL/P and 385
unaffected controls.
Results: None of the alleles and genotypes showed association with NSCL/P, though there was a significant
association of the haplotype formed by VAX1 rs10787760, rs6585429 and rs1871345 polymorphisms with NSCL/P
that did not persist Bonferroni correction for multiple tests.
Conclusions: Our results are consistent with a lack of involvement of FGF12, VCL and CX43 variants with NSCL/P
pathogenesis in Brazilian patients. Furthermore, the higher frequency of a haplotype of VAX1 with NSCL/P patients
suggests a low penetrant gene for oral cleft, and warrants further studies.
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Nonsyndromic cleft lip with or without cleft palate
(NSCL/P) is the most common human craniofacial defect
with a prevalence ranging from 0.36-1.54 per 1,000 live
births in Brazil [1,2]. With a population exceeding 190
million people and 3 million babies born every year,
NSCL/P is an important problem of public health in Brazil
with approximately 4,000 NSCL/P new cases every
year. Although the exact environmental and genetic
risk factors associated with NSCL/P remains unclear,
the understanding of the genetic mechanisms involved
in this malformation are evolving [3,4]. To date interferon* Correspondence: coletta@fop.unicamp.br
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distribution, and reproduction in any mediumregulatory factor 6 (IRF6) at 1q32.2 and the region 8q24
have been considered the most reliable susceptibility
markers for NSCL/P [5-11]. Our previous studies con-
firmed the association of 8q24 locus with NSCL/P suscepti-
bility in the Brazilian population [12], but the involvement
of IRF6 in NSCL/P pathogenesis is still unclear in Brazilians
[13,14]. As result of five centuries of mating between
Amerindians, Europeans and sub-Saharan Africans, the
Brazilian population displays very high levels of genomic
diversity [15], which may have important implications on
NSCL/P susceptibility.
Nonsyndromic oral clefts are traditionally divided in
cleft lip only (CLO), cleft lip and palate (CLP) and cleft
palate only (CPO), however, as there are similarities in
both epidemiologic features and embryologic timing for
both CLO and CLP, they are considered variants of thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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lip with or without cleft palate (CL/P). A recent study with
1536 markers in 357 candidate genes for oral clefts was
carried out with two Scandinavia-based populations, reveal-
ing significant association of CLO with variants in fibroblast
growth factor 12 (FGF12, MIM 601513), vinculin (VCL,
MIM 193065), connexin 43 (CX43, MIM 121014) and
IRF6 [16]. The haplotype relative risk ranged from 1.47
for VCL haplotype in the Norway dataset to 5.49, which
was identified for FGF12 in the Denmark cohort. FGF12
gene encodes an intracellular non-secretory protein of
the large family of FGFs [17]. While the role of the
secretory members of the FGF family in the control of
the cell growth, differentiation and morphogenesis, which
includes craniofacial development, is best known, the
functions of the intracellular members remain partially
determined [18]. Intracellular FGFs, including FGF12,
contain nuclear localization signals, suggesting a role
as transcriptional factors [19]. VCL encodes a small actin-
bundling protein that has emerging role in the organization
of the focal adhesions and adherens junctions [20]. Recent
developments advance our understanding of the VCL role
on regulation of cell adhesion and motility in both normal
development and cancer. Although VCL expression was
detected both in vivo during palate formation [21] and
in vitro in palatal fibroblast cell cultures [22], the participa-
tion of VCL on lip and palate embryogenesis is unknown.
CX43 is one of the 21 members of the homogeneous family
of connexin proteins, which are structurally and function-
ally associated with the formation of the gap junctions [23].
Gap junctions are essential for proper cell homeostasis and
have been shown to play important roles in a wide variety
of biological and pathological processes [24]. Mutations
in CX43 gene cause oculodentodigital dysplasia, which
is characterized among several clinical phenotypes by
the presence of cleft lip and/or cleft palate [25,26].
Another risk locus for NSCL/P identified in two large
genome-wide association studies is located on chromosome
10q25.3, which encompasses an intergenic region with
suggested regulatory effects on adjacent genes, specifically
ventral anterior homeobox 1 (VAX1) [9,27]. However, the
full-sequencing of 384 patients with NSCL/P and 384
controls did not support the association of VAX1 with
NSCL/P [28]. The purpose of the present study was to
investigate the contribution of FGF12, VCL, CX43 and
VAX1 risk markers with NSCL/P in Brazilian patients
through a structured analysis in which the genetic ancestry
variation of each individual was taken into account.
Methods
Sample study
In this case–control study, 300 patients with NSCL/P
assisted at the Center for Rehabilitation of Craniofacial
Anomalies, Dental School, University of José RosárioVellano, Brazil and 385 unaffected controls, which were
chosen among subjects admitted as in-patients in the Den-
tal School of the same University with conditions unrelated
to clefting disorders, were included. Samples were recruited
between 2008 and 2012, and all subjects were born in the
study area, South of Minas Gerais State, Brazil. The Center
for Rehabilitation of Craniofacial Anomalies of the Dental
School, University of Alfenas is the reference hospital
for clefting patients living in this area. To confirm the
NSCL/P diagnosis, all patients were carefully examined
and screened for the presence of associated anomalies
or syndromes by the team of the Center for Rehabilitation
of Craniofacial Anomalies. Patients with additional con-
genital malformations (other than NSCL/P), history of
consanguinity or with history of familial oral cleft were
not included in this study. The nonsyndromic clefts
were classified with the incisive foramen as reference,
and 105 patients had CLO and 195 had cleft lip and palate
(CLP). Control group was composed by healthy subjects
without history of congenital malformations or familial
history of oral clefting. Written informed consents were
obtained and the study carried out with approval of the
Human Research Ethics Committee of the University.
Polymorphism selection
Ten single nucleotide polymorphisms (SNPs) previous
detected in association with CLO by Jugessur et al. [16],
including rs6790664, rs11717284, rs1464942, rs12106855
and rs1875735 in FGF12, rs4746172, rs10762573 and
rs2131960 in VCL and rs11961755 and rs12197797 in
CX43, were evaluated in this study. In addition, 6 SNPs
in VAX1 with a minor allele frequency (MAF) >0.2
(rs7086344, rs10787760, rs6585429, rs1871345, rs751231
and rs751233) were identified in the International HapMap
Project (http://hapmap.ncbi.nlm.nih.gov/) and included in
this study. The main features of each polymorphism,
including chromosome position, localization within gene,
identification of the major and minor alleles and MAF, are
described in Table 1.
SNP genotyping and estimation of the genomic ancestry
Genomic DNA was extracted from oral mucosa cells
and examined blinded to group status using the
TaqMan 5′-exonuclease allelic discrimination assay
(Applied Biosystems, Foster City, CA). Genotyping ana-
lyses were randomly repeated in 10% of the samples for all
polymorphisms. To determine the genomic ancestry of each
individual, samples were genotyped for a set of 40 biallelic
short insertion/deletion polymorphisms (INDELs) previ-
ously validated as informative markers for ancestry [29].
Statistical analysis
Deviation from Hardy-Weinberg equilibrium in control
group was assessed through chi-square test. To determine
Table 1 Characteristics of the single nucleotide
polymorphisms of the present study
Chromosome
position*
Location Allele Minor allele
frequency*
FGF12 (3q28)
rs11717284 191925200 Intron A/t 0.353
rs6790664 191939237 Intron C/a 0.392
rs1464942 192086644 Intron T/a 0.253
rs12106855 192346410 Intron G/a 0.467
rs1875735 192359833 Intron G/c 0.426
VCL (10q22.2)
rs10762573 75798148 Intron C/a 0.398
rs2131960 75831259 Intron A/c 0.404
rs4746172 75855842 Intron T/c 0.360
CX43 (6q21-q23.2)
rs12197797 121763963 Intron C/g 0.164
rs11961755 121766286 Intron G/a 0.164
VAX1 (10q26.1)
rs7086344 118890573 Exon C/t 0.266
rs10787760 118890693 Exon G/a 0.483
rs6585429 118893231 Exon G/a 0.412
rs1871345 118895368 Intron C/t 0.317
rs751231 118896664 Intron A/c 0.267
rs751233 118896767 Intron G/a 0.228
*Reference: http://www.ncbi.nlm.nih.gov.
Table 2 Gender distribution and proportions of the
European, African and Amerindian ancestry of each group
Gender Ancestry
Male Female European African Amerindian
Control 51.4% 48.6% 90% 7.5% 2.5%
CL ± P 55.2% 44.8% 87.5% 10.7% 1.8%
CLO 57% 43% 87% 11.2% 1.8%
CLP 53.3% 46.7% 88.2% 10.1% 1.7%
CL ± P: cleft lip with or without cleft palate, CLO: cleft lip only, CLP: cleft lip
and palate.
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was utilized [30] in a model assuming K = 3 parental
populations based on the tri-hybrid origin of the Brazilian
population. Samples with pre-specified population of origin
(European, Sub-Saharan African and Amerindian reference
populations from Marshfield Clinic Collection) were also
incorporated to assist the software in the ancestry estima-
tion. Following ancestry assessment, STRAT was used to
test the association, conditioning on the individual ancestry
proportions [31]. The odds ratio (OR) and associated
95% confidence intervals (95% CI) were also calculated.
Haplotype frequencies and pair-wise linkage disequilibrium
(D’ and r2) were estimated using the HaploView software.
The Bonferroni correction for multiple comparisons was
applied, and the corrected p value of ≤0.003 was considered
statistically significant.
Results
The description of study participants’ gender and the
proportions of ancestry of each group are depicted in
Table 2. Initially each sample was genotyped with 40
INDEL markers and the data were analyzed using the
Structure program. To assist the software in the estimation of
the ancestry, we incorporated reference samples of European,
African and Amerindian ancestry from Marshfield Cliniccollection. The average ancestry contributions were
estimated at 90% of European, 7.5% of African, and
2.5% of Amerindian in the control group, and in the
NSCL/P group was 87.5% of European, 10.7% of African,
and 1.8% of Amerindian, revealing no statistical significant
differences in the proportions between groups (p = 0.32).
Additional file 1: Figure S1 depicts the proportions of
the Amerindian, European, and African ancestry of
each sample.
Frequencies of the alleles and genotypes of FGF12,
CX43, VCL and VAX1 polymorphisms structured by
genomic ancestry are presented in Table 3. The genotype
frequencies observed for all studied polymorphisms in
controls did not reveal statistically significant differences
compared to those expected under Hardy-Weinberg
equilibrium. None of the polymorphisms tested showed
association with NSCL/P or its subtypes (CLO and CLP)
in this Brazilian case–control cohort (Table 3). Further
analyses in the dominant and recessive genetic models
also revealed no differences in the distribution between
groups (Figure 1).
Pair-wise linkage disequilibrium analyses are depicted
in Figure 2. One linkage disequilibrium block, which
involved rs10787760, rs6585429 and rs1871345, was
identified in VAX1. Carriers of the VAX1 G-A-C haplotype
(G allele of rs10787760, A allele of rs6585429 and C allele
of rs1871345) were found to be more frequent in all NSCL/
P groups as compared to controls (Table 4), but those
significances did not remain after correction for multiple
testing by the conservative Bonferroni procedure. FGF12
polymorphisms rs11717284 and rs6790664 (D’ = 0.90 and
r2 = 0.70), VCL rs10762573 and rs2131960 (D’ = 0.88 and
r2 = 0.77) and CX43 polymorphisms (D’ = 0.97 and r2 = 0.94)
were in linkage disequilibrium (Figure 2). Interestingly, 3
out of 4 risk haplotypes identified in the study of Jugessur
et al. [16] were composed of the major alleles and were the
most prevalent in the present cohort (Table 4).
Discussion
Although NSCL/Ps are amongst the most common and
distressing congenital defects, the exact genetic and
environmental events associated with their pathogenesis
Table 3 Case–control frequencies of the alleles and genotypes of the polymorphisms on FGF12, VCL, CX43 and VAX1
HWE* (p value) Control Group (%) CL ± P Group (%) ORallele (95% CI)
p value
CLO Group (%) ORallele (95% CI)
p value




Allele (A/C) 0.79 50.5/49.5 50.5/49.5 1.00 (0.80-1.24) 55.3/44.7 0.83 (0.61-1.12) 48/52 1.11 (0.87-1.41)
Genotype (AA/AC/CC) 25.2/50.6/24.2 24.7/51.7/23.6 0.50 28.6/53.4/18 0.28 22.6/50.7/26.7 0.56
rs11717284
Allele (A/T) 0.42 51.5/48.5 55.5/44.5 0.85 (0.68-1.06) 49/51 1.10 (0.81-1.50) 59/41 0.74 (0.58-0.95)
Genotype (AA/AT/TT) 27.6/47.9/24.5 30.5/50.1/19.4 0.36 22.1/53.9/24 0.22 34.9/48.2/16.9 0.91
rs1464942
Allele (A/T) 0.06 27.8/72.2 29.6/70.4 0.91 (0.72-1.16) 31/69 0.85 (0.61-1.19) 28.9/71.1 0.94 (0.72-1.24)
Genotype (AA/AT/TT) 9.6/36.4/54 8.7/41.8/49.5 0.74 8.6/44.8/46.6 0.59 8.8/40.2/51 0.50
rs12106855
Allele (A/G) 0.15 42.1/57.9 40.8/59.2 1.05 (0.85-1.31) 43.3/56.7 0.95 (0.69-1.29) 39.3/60.7 1.12 (0.87-1.43)
Genotype (AA/AG/GG) 19.5/45.2/35.3 17.2/47/35.8 0.23 17.1/52.4/30.5 0.22 17.3/44.1/38.6 0.53
rs1875735
Allele (C/G) 0.14 46.1/53.9 46.8/53.2 0.97 (0.78-1.20) 44.8/55.2 1.06 (0.77-1.43) 48/52 0.93 (0.72-1.18)
Genotype (CC/CG/GG) 23.1/46/30.9 23.4/47/29.6 0.44 21/47.6/31.4 0.28 24.6/46.7/28.7 0.76
VCL
rs4746172
Allele (C/T) 0.89 27.2/72.8 27.2/72.8 1.00 (0.78-1.27) 24.3/75.7 1.16 (0.82-1.66) 28.7/71.3 0.93 (0.71-1.22)
Genotype (CC/CT/TT) 7.5/39.3/53.2 7/40.4/52.6 0.83 2.9/42.8/54.3 0.92 9.2/39/51.8 0.59
rs10762573
Allele (A/C) 0.46 33.9/66.1 32.8/67.2 1.05 (0.83-1.32) 34.3/65.7 0.98 (0.71-1.35) 32/68 1.09 (0.84-1.42)
Genotype (AA/AC/CC) 10.6/46.5/42.9 12.7/40.2/47.1 0.94 16.2/36.2/47.6 0.57 10.8/42.2/47 0.92
rs2131960
Allele (A/C) 0.45 62.6/34.4 67.9/32.1 0.90 (0.72-1.13) 68.8/31.2 0.87 (0.62-1.21) 67.5/32.5 0.92 (0.71-1.19)
Genotype (AA/AC/CC) 42.1/46.9/11 47.5/40.8/11.7 0.62 50/37.5/12.5 0.23 46.1/42.6/11.3 0.95
CX43
rs11961755
Allele (A/G) 0.73 20.4/79.6 21.9/78.1 0.91 (0.70-1.19) 21.4/78.6 0.94 (0.64-1.36) 22/78 0.90 (0.67-1.22)
Genotype (AA/AG/GG) 4.4/31.9/63.7 4.4/35/60.6 0.68 2.9/37.1/60 0.90 5.2/33.8/61 0.74
rs12197797
Allele (C/G) 0.70 79/21 79/21 0.99 (0.76-1.29) 78.7/21.3 1.02 (0.70-1.49) 79.3/20.7 0.98 (0.72-1.33)





















Table 3 Case–control frequencies of the alleles and genotypes of the polymorphisms on FGF12, VCL, CX43 and VAX1 (Continued)
VAX1
rs7086344
Allele (C/T) 0.23 82/18 82.5/17.5 0.96 (0.73-1.27) 82.4/17.6 0.97 (0.65-1.45) 82.6/17.4 0.96 (0.69-1.32)
Genotype (CC/CT/TT) 68/27.8/4.2 69.7/25.7/4.6 0.12 66.7/31.4/1.9 0.63 71.3/22.6/6.1 0.16
rs10787760
Allele (A/G) 0.11 63.6/36.4 62.7/37.3 1.04 (0.83-1.290 61.9/38.1 1.07 (0.78-1.47) 63/37 1.02 (0.79-131)
Genotype (AA/AG/G) 42.3/42.6/15.1 39.7/46/14.3 0.42 40/43.8/16.2 0.85 39.5/47.1/13.4 0.46
rs6585429
Allele (A/G) 0.09 26.3/73.7 30.4/69.6 0.82 (0.64-1.04) 32/68 0.75 (0.54-1.06) 29.5/70.5 0.85 (0.65-1.12)
Genotype (AA/AG/GG) 8.6/35.4/56 9.8/41.2/49 0.43 11.6/40.8/47.6 0.46 8.7/41.5/49.8 0.72
rs1871345
Allele (C/T) 0.06 76/24 75.6/24.4 1.02 (0.79-1.31) 74.3/25.7 1.09 (0.77-1.56) 76.3/23.7 0.98 (0.74-1.31)
Genotype (CC/CT/TT) 59.5/32.9/7.6 56.6/38/5.4 0.96 55.4/37.8/6.8 0.56 57.2/38.1/4.7 0.85
rs751231
Allele (A/C) 0.34 81.5/18.5 80.1/19.9 1.09 (0.83-1.43) 78.9/21.1 1.18 (0.80-1.72) 80.8/19.2 1.04 (0.76-1.42)
Genotype (AA/AC/CC) 67.1/28.8/4.1 63.3/33.7/3 0.83 61.5/34.6/3.9 0.16 64.3/33.1/2.6 0.91
rs751233
Allele (A/G) 0.47 17/83 19.5/80.5 0.84 (0.64-1.11) 20.7/79.3 0.78 (0.53-1.15) 18.9/81.1 0.87 (0.64-1.20)
Genotype (AA/AG/GG) 3.4/27.1/69.5 3.7/31.6/64.7 0.58 3.8/33.7/62.5 0.24 3.6/30.6/65.8 0.83





















Figure 1 Odds ratio values under the dominant and recessive genetic models. In the dominant analysis, it was assumed that the
heterozygote and the rare homozygote have the same disease odds, whereas in the recessive model the rare homozygote has different disease
odds compared to the common homozygote and heterozygote. Those analyses did not show significant changes in the odds ratio.
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ations will have important impacts on genetic counseling,
and will lead to a greater understanding of the craniofacial
development. In the present study, we evaluated the associ-
ation of polymorphisms in FGF12, VCL, CX43 and VAX1
with NSCL/P in a representative sample of the BrazilianFigure 2 Linkage disequilibrium plots with the single nucleotide poly
generated using the HaploView software. The numbers in the squares indic
polymorphisms (D′ value). Only for VAX1 gene a clear block formed by rs10population through a structured approach. In contrast to
the results of Jugessur et al. [16], we have not observed any
association of FGF12, VCL and CX43 with CLO. No
association with CLP or the combination of CLO and
CLP (CL ± P) was also found. The lack of association
observed in our cohort may be related to sample size,morphisms within the genes of this study. The plots were
ate the percentage linkage disequilibrium between a given pair of
787760, rs6585429 and rs1871345 polymorphisms was identified.
Table 4 Distribution of the risk haplotypes
Tagging polymorphisms Candidate risk
haplotype*
Control group CL ± P group P value CLO group P value CLP group P value
FGF12 A-C-T 34.9% 35.5% 0.46 32.1% 0.73 37.2% 0.65
rs11717284, rs6790664, rs1464942
FGF12 A-G-G 3.9% 2.7% 0.40 2.4% 0.77 2.9% 0.81
rs1464942, rs12106855, rs1875753
VCL C-A-T 53.5% 56.8% 0.44 58.3% 0.37 55.8% 0.59
rs10762573, rs2131960, rs4746172
CX43 C-G 78.8% 77.6% 0.78 78.1% 0.89 77.4% 0.75
rs12197797, rs11961755
VAX1 G-A-C 2.6% 6.7% 0.026 6.9% 0.19 6.7% 0.033
rs10787760, rs6585429, rs1871345
*Risk haplotypes of FGF12, VCL and CX43 were based on Jugessur et al. (2011).
CL ± P: cleft lip with or without cleft palate, CLO: cleft lip only, CLP: cleft lip and palate.
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oral cleft risk may have been missed. However, the
number of CLO samples in this study was quite similar
to the Scandinavian datasets (121 CLO from Norway
and 76 from Denmark compared with 105 CLO in the
current study) that identified significant associations
with CLO risk. Furthermore, a frequency of the risk
alleles for all polymorphisms in our sample was similar
to those observed in the European population (CEU data-
base, Single Nucleotide Polymorphism database-dbSNP).
Taken that the frequency of the risk alleles is high in
European populations and our sample was enriched
by European descents, it is unlikely that these poly-
morphisms are involved with NSCL/P pathogenesis in
Brazilian patients.
Two independent genome-wide scans identified poly-
morphic variants at region 10q25.3 as risk markers for
NSCL/P, with rs7078160 showing the highest significant
score [9,27]. However, later studies lacked to confirm this
association in populations from China [32] and Brazil [33].
As an intergenic region, it is unknown whether markers at
10q25.3 are the cause of the association or are in linkage
disequilibrium with adjacent causal variants in the genes.
Assuming the later hypothesis, VAX1 has been suggested
to be the strongest candidate near 10q25.3, because VAX1
knockout mice showed craniofacial malformations in-
cluding cleft palate and VAX1 mutation was described
in a patient affected by an uncharacterized syndrome
with bilateral CLP as one of the clinical features
[34,35]. Nasser et al. [28] recently described the sequencing
analysis of 384 patients with NSCL/P and 384 controls of
Central European origin and identified a large number of
VAX1 rare variants, but no significant associations with
NSCL/P were found. Nevertheless, the authors demon-
strated the segregation of the identified VAX1 rare variants
in six NSCL/P structured families, suggesting the VAX1
may have a low penetrance effect on NSCL/P pathogenesis[28]. Although two of the selected VAX1 polymorphisms of
the present study demonstrated a suggestive protective
effect against NSCL/P (odds ratio < 1), none of them
was significantly associated with oral clefts. On the
other hand, the higher frequency of the G-A-C haplo-
type in NSCL/P patients suggests that this may be a
disease-promoting gene, but there are some limitations
in this interpretation. First, the association did not reach
significance after Bonferroni correction. Fundamentally,
correction for multiple testing is always required when
multiple markers (comparisons) are used, correcting
for spurious associations. However, Bonferroni correc-
tion is especially emblematic with markers in linkage
disequilibrium because the alleles are not independent
of each other, making the correction too conservative.
A less conservative and more realistic procedure is to
identify markers or blocks of linkage disequilibrium
reducing the number of comparisons. Assuming link-
age disequilibrium between markers with r2 ≥ 0.70, the
number of independent comparisons was reduced to
10, requiring α level of 0.005 to give a 95% probability
of correctly concluding not to reject H0. Nevertheless,
the p level of the VAX1 haplotypes was still beyond the
significance level. Second, the frequency of the risk
haplotype was relatively low, and to establish more firmly
the association of this haplotype with the disease, confirm-
ation with a larger number of samples is necessary.
Conclusion
In summary, our results show a lack of involvement of
polymorphisms in FGF12, VCL and CX43 with the
pathogenesis of NSCL/P in Brazilian patients, and the
higher frequency of G-A-C haplotype formed by VAX1
polymorphisms in NSCL/P suggests that this gene may
be involved with the defect. Further efforts are needed
to clarify the relationship between genetic variations of
the VAX1 gene and the development of NSCL/P.
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Additional file 1: Figure S1. Genomic proportions of the European,
African and Amerindian ancestry in the unaffected control and
nonsyndromic cleft lip with or without cleft palate (NSCL/P) groups. Each
individual is represented by a single column, and the columns identified
as EUR (European), AFR (African), and AMI (Amerindian) represent the
parental populations used to assist the structure in estimating ancestry of
the admixed individuals.
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